Benedetti, F., Amanzio, M., Casadio, C., Oliaro, A., & Maggi, G. (1997). Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain, 71, 135–140.PubMed
Benedetti, F., Amanzio, M., Baldi, S., Casadio, C., & Maggi, G. (1999). Inducing placebo respiratory depressant responses in humans via opioid receptors. European Journal of Neuroscience, 11, 625–631.PubMed
Benedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S., & Rainero, I. (2003). Conscious expectation and unconscious conditioning in analgesic, motor and hormonal placebo/nocebo responses. Journal of Neuroscience, 23, 4315–4323.PubMed
Benedetti, F., Arduino, C., Costa, S., Vighetti, S., Tarenzi, L., Rainero, I., et al. (2006a). Loss of expectation-related mechanisms in Alzheimer’s disease makes analgesic therapies less effective. Pain, 121, 133–144.PubMed
Benedetti, F., Amanzio, M., Vighetti, S., Asteggiano, G. (2006b). The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. Journal of Neuroscience, 26, 12014–12022.PubMed
Benedetti, F., Lanotte, M., Lopiano, L., Colloca, L. (2007). When words are painful: Unraveling the mechanisms of the nocebo effect. Neuroscience, 147, 260–271.PubMed
Benedetti, F., Carlino, E., & Pollo, A. (2011a). How placebos change the patient’s brain. Neuropsychopharmacology, 36, 339–354. doi:10.1038/npp 2010.81.PubMed
Benedetti, F., Amanzio, M., & Thoen, W. (2011b). Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors. Psychopharmacology, 213, 791–797. doi:10.1007/s00213-010-2037-y.PubMed
Bingel, U., Lorenz, J., Schoell, E., Weiller, C., & Büchel, C. (2006). Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain, 120, 8–15.PubMed
Charron, J., Rainville, P., & Marchand, S. (2006). Direct comparison of placebo effects on clinical and experimental pain. The Clinical Journal of Pain, 22, 204–211.PubMed
Chua, P., Krams, M., Toni, I., Passingham, R. & Dolan, R. (1999). A functional anatomy of anticipatory anxiety. NeuroImage, 9, 563–571.PubMed
Colloca, L., & Benedetti, F. (2005). Placebos and painkillers: Is mind as real as matter? Nature Reviews. Neuroscience, 6, 545–552.PubMed
Colloca, L., & Benedetti, F. (2006). How prior experience shapes placebo analgesia. Pain, 124, 126–133.PubMed
Colloca, L., & Benedetti, F. (2007). Nocebo hyperalgesia: How anxiety is turned into pain. Current Opinion in Anaesthesiology, 20, 435–439.PubMed
Colloca, L., & Benedetti, F. (2009). Placebo analgesia induced by social observational learning. Pain, 144, 28–34.PubMed
Colloca, L., Lopiano, L., Lanotte, M., & Benedetti, F. (2004). Overt versus covert treatment for pain, anxiety, and Parkinson’s disease. Lancet Neurology, 3, 679–684.PubMed
Colloca, L., Benedetti, F., & Porro, C. A. (2008a). Experimental designs and brain mapping approaches for studying the placebo analgesic effect. European Journal of Applied Physiology, 102, 371–380.PubMed
Colloca, L., Sigaudo, M., & Benedetti, F. (2008b). The role of learning in nocebo and placebo effects. Pain, 136, 211–218.PubMed
Colloca, L., Tinazzi, M., Recchia, S., Le Pera, D., Fiaschi, A., Benedetti, F., et al. (2009). Learning potentiates neurophysiological and behavioral placebo analgesic responses. Pain, 139, 306–314.PubMed
de la Fuente-Fernández, R. (2010). The placebo-reward hypothesis: Dopamine and the placebo effect. Parkinsonism & Related Disorders, 15(S3), S72–S74.
de la Fuente-Fernández, R., & Stoessl, A. J. (2002). The placebo effect in Parkinson’s disease. Trends in Neurosciences, 6, 302–306.
de la Fuente-Fernández, R., Ruth, T. J., Sossi, V., Schulzer, M., Calne, D. B., & Stoessl, A. J. (2001). Expectation and dopamine release: Mechanism of the placebo effect in Parkinson’s disease. Science, 293, 1164–1166.PubMed
de la Fuente-Fernández, R., Phillips, A. G., Zamburlini, M., Sossi, V., Calne, D. B., Ruth, T. J. et al. (2002). Dopamine release in human ventral striatum and expectation of reward. Behavioural Brain Research, 136, 359–363.PubMed
Eippert, F., Finsterbusch, J., Bingel, U., & Büchel, C. (2009a). Direct evidence for spinal cord involvement in placebo analgesia. Science, 326, 404.PubMed
Eippert, F., Bingel, U., Schoell, E. D., Yacubian, J., Klinger, R., Lorenz, J., et al. (2009b). Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron, 63, 533–543.PubMed
Enck, P., Benedetti, F., & Schedlowski, M. (2008). New insights into the placebo and nocebo responses. Neuron, 59, 195–206.PubMed
Giang, D. W., Goodman, A. D., Schiffer, R. B., Mattson, D. H., Petrie, M., Cohen, N., et al. (1996). Conditioning of cyclophosphamide-induced leukopenia in humans. The Journal of Neuropsychiatry and Clinical Neurosciences, 8, 194–201.PubMed
Goebel, M. U., Trebst, A. E., Steiner, J., Xie, Y. F., Exton, M. S., Frede, S., et al. (2002). Behavioral conditioning of immunosuppression is possible in humans. The FASEB Journal, 16, 1869–1873.
Goffaux, P., Redmond, W. J., Rainville, P., & Marchand, S. (2007). Descending analgesia – When the spine echoes what the brain expects. Pain, 130, 137–143.PubMed
Gospic, K., Gunnarsson, T., Fransson, P., Ingvar, M., Lindefors, N., & Petrovic, P. (2008). Emotional perception modulated by an opioid and a cholecystokinin agonist. Psychopharmacology, 197, 295–307.PubMed
Gracely, R. H., Dubner, R., Wolskee, P. J., & Deeter, W. R. (1983). Placebo and naloxone can alter post-surgical pain by separate mechanisms. Nature, 306, 264–265.PubMed
Gracely, R. H., Dubner, R., Deeter, W. D., & Wolskee, P. J. (1985). Clinician’s expectations influence placebo analgesia. The Lancet, 5, 43.
Grevert, P., Albert, L. H., & Goldstein, A. (1983). Partial antagonism of placebo analgesia by naloxone. Pain, 16, 129–143.PubMed